Skip to content
10-Q

Quarterly Report

NUTRA PHARMA CORP. NPHC

0001493152-25-018328

← back to feed
Filed
Oct 16, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Oct 16, 2025 7.1B sh
Short Term Debt Q1 2023 · Mar 31, 2023 $8.04M
Short Term Debt Q1 2023 · Dec 31, 2022 $7.93M
Current Liabilities Q1 2023 · Mar 31, 2023 $13.3M
Current Liabilities Q1 2023 · Dec 31, 2022 $12.7M
Total Liabilities Q1 2023 · Mar 31, 2023 $13.69M
Total Liabilities Q1 2023 · Dec 31, 2022 $13.13M
Current Assets Q1 2023 · Mar 31, 2023 $327.79K
Current Assets Q1 2023 · Dec 31, 2022 $333.58K
Total Assets Q1 2023 · Mar 31, 2023 $724.88K
Total Assets Q1 2023 · Dec 31, 2022 $754.91K
Shares Diluted Q1 2023 · Mar 31, 2022 14.5B sh
Capex Q1 2023 · Mar 31, 2022 $57.99K
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$258.23K
Stockholders Equity Q1 2023 · Mar 31, 2022 −$15.77M
Stockholders Equity Q1 2023 · Dec 31, 2021 −$20.88M
Eps Diluted Q1 2023 · Mar 31, 2022 $0.00
Eps Basic Q1 2023 · Mar 31, 2022 $0.00
Sga Expense Q1 2023 · Mar 31, 2022 $316.22K
Net Income Q1 2023 · Mar 31, 2022 $5.01M
Operating Income Q1 2023 · Mar 31, 2022 −$308.42K
Gross Profit Q1 2023 · Mar 31, 2022 $7.79K
Revenue restated Q1 2023 · Mar 31, 2022 $13.76K